Patent granted for work done by disgraced Hwang Woo-suk team

February 24, 2014 by Bob Yirka report

The United States Patent and Trademark Office (USPTO) has granted a patent to Hwang Woo-suk for the technology behind the controversial work he and his team did a decade ago—at the time it was announced that the team had succeeded in cloning a human embryo and had even created a stem cell line to "prove" it. Shortly thereafter, however, the work by the team was discredited. The granting of a patent to the team does not suggest that the work done was in fact successful, but it has set off a round of criticism in the scientific community about the rubber-stamping of patents and the impact that it can have.

Hwang had his colleagues received international acclaim after they published a paper in the journal Science, describing their work—government officials in his home country of South Korea, fawned over him, describing him as a national hero. Unfortunately, it wasn't long before other scientists began finding problems with the work, and over time, it was found that Hwang and his team had faked their findings. Hwang was fired and prosecuted for misusing funds, though he still insists that the work he and his team did was real. Today, he heads an independent laboratory looking into cloning animals—the government has banned him from working on human cloning.

Hwang applied for patents on the work done by his team in countries across the globe, they've been granted in Australia, and Canada, and now the United States. The value of the , however, is still debatable, as a patent on technology that doesn't work is generally considered to be worthless. Still, the issuing of a patent for work that is known to be fraudulent has rankled many in the science and technology fields. The granting of a patent doesn't give any credence to scientific work, of course, but it does, apparently, offer some degree of respectability—or at least the perception of it.

Representatives for USPTO have acknowledged that they have known all along about the fraud perpetuated by the research team, but offer a reminder that the still operates on the honor code—the office could not possibly verify that every patent it grants produces the outcome its maker claims. All that is required is that the application fulfills the requirements of the patent application process—Hwang and his team did just that and thus the patent was granted.

Explore further: Silicon Valley patent office shelved

Related Stories

Silicon Valley patent office shelved

September 1, 2013
Silicon Valley's high tech firms are fighting what they consider a deeply personal federal cut this summer that shelves a planned patent office in this innovation-fueled region.

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.